[Risk factors and clinical prognosis analysis of carbapenem-resistant bacteria nosocomial infection].

To explore the risk factors for carbapenem-resistant (CRE) infection and death. A case-control analysis of 482 inpatients in 18 secondary or tertiary hospitals in Beijing in 2018 was conducted. Patients infected by CRE were selected as the case group (247), and infected by carbapenem susceptible (CSE) as the control group (235). The risk factors and clinical prognosis of CRE infection were analyzed by single factor analysis and multivariate logistic regression analysis. CRE were resistant to most antimicrobials, but were highly sensitive to colistin and tigecycline, with sensitivity of 94.0% and 99.5%, respectively. Multivariate analysis showed that prior 30-day tracheal intubation (2.607, 95: 1.655-4.108, 0.001), empirical treatment using third or fourth generation cephalosporins (2.339, 95: 1.438-3.803, 0.001), carbapenems (2.468, 95: 1.610-3.782, 0.001) and quinolones (2.042, 95: 1.268-3.289, 0.003) were independent risk factors for CRE infection. Mechanical ventilation (3.390, 95: 1.454-7.904, 0.005), heart failure (4.679, 95: 1.975-11.083, 0.001), moderate or severe liver disease (3.057, 95: 1.061-8.806, 0.038), prior 30-day quinolones exposure (2.882, 95: 1.241-6.691, 0.014) and septic shock (7.772, 95: 3.505-17.233, 0.001) were independent risk factors for death after CRE infection. Reducing the use of antimicrobials and invasive procedures such as prior 30-day tracheal intubation may reduce the probability of CRE infection. Grading the severity of the underlying disease in patients with CRE infection, as well as predicting and preventing the occurrence of septic shock will help reduce the risk of death.